| 000 | 01741 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513162334.0 | ||
| 264 | 0 | _c19990216 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1998.tb11215.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRodier, G | |
| 245 | 0 | 0 |
_aA target cell to oxyntomodulin and glicentin: the antral smooth muscle cell. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cDec 1998 |
||
| 300 |
_a458-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Membrane Permeability |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aGlicentin |
| 650 | 0 | 4 |
_aGlucagon _xpharmacology |
| 650 | 0 | 4 | _aGlucagon-Like Peptide 1 |
| 650 | 0 | 4 |
_aGlucagon-Like Peptides _xpharmacology |
| 650 | 0 | 4 |
_aGuanosine 5'-O-(3-Thiotriphosphate) _xpharmacology |
| 650 | 0 | 4 |
_aGuanosine Diphosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth _xdrug effects |
| 650 | 0 | 4 | _aOxyntomodulin |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 |
_aPeptides _xmetabolism |
| 650 | 0 | 4 |
_aProtein Precursors _xpharmacology |
| 650 | 0 | 4 | _aPyloric Antrum |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aStomach _xdrug effects |
| 650 | 0 | 4 |
_aThionucleotides _xpharmacology |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xmetabolism |
| 700 | 1 | _aMagous, R | |
| 700 | 1 | _aMochizuki, T | |
| 700 | 1 | _aBali, J P | |
| 700 | 1 | _aBataille, D | |
| 700 | 1 | _aJarrousse, C | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 865 _gp. 458-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1998.tb11215.x _zAvailable from publisher's website |
| 999 |
_c9889693 _d9889693 |
||